MedTrace Logo

Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens

NCT01197859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2020-08-12

No results posted yet for this study

Summary

The purpose of this study is to compare the clinical performance of the contamac silicone hydrogel contact lens with a predicate device (Cooper Vision Biofinity).

Conditions

  • Vision Correction

Interventions

DEVICE

Definitive Contact Lens

Daily wear contact lens

DEVICE

Biofinity

Daily wear contact lens

Sponsors & Collaborators

  • Contamac Ltd

    lead INDUSTRY

Principal Investigators

  • Graeme Young · Vision Care Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197859 on ClinicalTrials.gov